Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2000
05/04/2000WO2000024728A1 Microbial transformation product
05/04/2000WO2000024727A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME
05/04/2000WO2000024724A1 Thiazole-derivatives
05/04/2000WO2000024437A2 Textured and porous silicone rubber
05/04/2000WO2000024426A1 Ribozymes used as prodrugs
05/04/2000WO2000024420A1 Method for the production of an antiviral agent
05/04/2000WO2000024411A2 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
05/04/2000WO2000024403A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024402A1 Use of antifungal agents for treating scleroses
05/04/2000WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000WO2000024391A2 Conductance of improperly folded proteins through the secretory pathway
05/04/2000WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/04/2000WO2000012741A3 Inducible expression system
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
05/04/2000WO2000006204A3 Genetically engineered cells and tissues
05/04/2000WO2000006187A3 Modulation of apoptosis
05/04/2000WO2000006085A3 Compounds and methods
05/04/2000WO1999067286A9 Novel staphylococcus peptides for bacterial interference
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/04/2000DE19916085A1 Antiviral agent, e.g. for treating HIV infections, comprising autovaccine obtained by heating blood containing viruses and antigens with protein crosslinking agent
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348840A1 Method for the production of an antiviral agent
05/04/2000CA2348833A1 Human phospholipases
05/04/2000CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348529A1 Conductance of improperly folded proteins through the secretory pathway
05/04/2000CA2348160A1 Use of antifungal agents for treating scleroses
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347911A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000CA2347803A1 Microbial transformation product
05/04/2000CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
05/04/2000CA2347128A1 Library of novel "unnatural" natural products
05/04/2000CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
05/03/2000EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof
05/03/2000EP0997466A1 Novel antimicrobial lactam-quinolones
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
05/03/2000EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
05/03/2000EP0996721A2 Secreted proteins and polynucleotides encoding them
05/03/2000EP0996717A2 Immunoprotective influenza antigen and its use in vaccination
05/03/2000EP0996712A2 Live attenuated vaccines
05/03/2000EP0996710A1 Component of bromelain
05/03/2000EP0996467A1 Txu-7-pap immunotoxin and use thereof
05/03/2000EP0996464A1 Multivalent in ovo avian vaccine
05/03/2000EP0996446A1 Novel substituted imidazole compounds
05/03/2000EP0996433A1 Methods for treatment of conditions associated with lactosylceramide
05/03/2000EP0996430A2 Nucleotide analog compositions
05/03/2000EP0721465B1 Glutathione s-transferase-activated compounds
05/03/2000EP0383803B1 Oligonucleotide-polyamide conjugates
05/03/2000CN1252101A Component of bromelain
05/03/2000CN1252096A Component of bromelain
05/03/2000CN1252075A Synthetic HIV GAG genes
05/03/2000CN1252072A Carbapenem compounds, use and intermediate compounds thereof
05/03/2000CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
05/03/2000CN1252064A Bicyclic amino acids
05/03/2000CN1252063A 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
05/03/2000CN1252058A Preparation of butylthio-isoquinoline and intermediate thereof
05/03/2000CN1251996A Combination therapy for HIV infections
05/03/2000CN1251994A Extended release formulations of erythromycin derivatives
05/03/2000CN1251993A Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
05/03/2000CN1251990A Pharmaceutical formulations comprising amoxocyllin and clavulanate
05/03/2000CN1251986A Diffusional implantable delivery system
05/03/2000CN1251969A Method for treating parillomarvirus infections
05/03/2000CN1251836A Preparation of intermediate for monocyclic beta-lactams derivatives
05/03/2000CN1052010C Benzimidazole derivatives, preparation and use thereof and medicines containing same
05/02/2000US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates
05/02/2000US6057453 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
05/02/2000US6057451 Anti-herpesvirus compounds and methods for identifying, making and using same
05/02/2000US6057450 Derivatives of pyroglutaminic acid preparation process and applications
05/02/2000US6057448 Reaction of halosulfide with imidazole to produce sulfide substituted imidazole
05/02/2000US6057445 Formation of carbon nitrogen bond, cyclization and halogenation
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
05/02/2000US6057364 Fluoro-substituted adamantane derivatives
05/02/2000US6057351 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals
05/02/2000US6057336 Lactam metalloprotease inhibitors
05/02/2000US6057327 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
05/02/2000US6057312 Cephalosporin antibiotics
05/02/2000US6057305 Antiretroviral enantiomeric nucleotide analogs
05/02/2000US6057295 Oligopeptides derived from C-reactive protein fragments
05/02/2000US6057294 Peptide
05/02/2000US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof
05/02/2000US6057153 Oligonucleotide composed of modified nucleotides and having a ribonuclease p cleavage targeting sequence and a recognition sequence complementary to target rna; for viricides to treat hepatitis b infections
05/02/2000US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/02/2000US6057115 Process for producing GM2 specific antibodies
05/02/2000US6057112 Ubiquitin conjugation proteins
05/02/2000US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules
05/02/2000US6056963 Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins
05/02/2000US6056961 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
05/02/2000US6056955 Topical treatment of streptococcal infections
05/02/2000US6056954 Treatment of skin infections, wounds, and burns, eye infections
05/02/2000CA2137176C Liponucleotide compounds
05/02/2000CA2109233C Process for producing vaccine for bacterial toxin belonging to rtx toxin family
05/02/2000CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man
05/02/2000CA2104014C Structural gene of pneumococcal protein
05/02/2000CA2090024C Phospholipid derivatives of nucleosides, their preparation, as well as their use as anti-viral medicaments
1 ... 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 ... 1798